Vivakor’s Chairman, Matt Nicosia stopped by SmallCapVoice.com to discuss Vivakor, a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. Vivakor generates revenues through the licensing or sale of its technologies.

TwitterStumbleUponFacebookLinkedInTechnorati FavoritesDeliciousDiggFarkNewsVineNetvibes SharePrintFriendlyGoogle GmailMySpaceBlogger PostAOL MailYahoo BookmarksWordPressYahoo MailShare

Comments are closed.

Sponsors